Dr. Reddy’s Laboratories is recalling 1,728 bottles of Rivastigmine Tartrate capsules, used for treatment of dementia, due to cross-contamination with other products from the US market. The company's US arm, Dr. Reddy’s Laboratories Inc is recalling Rivastigmine Tartrate capsules 1.5 mg in 60-count bottle manufactured by Dr. Reddy’s Laboratories in India.
As per the United States Food and Drug Administration (USFDA), a class III recall is initiated in a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
